key: cord-1053142-kx0n2oy5
authors: Qiu, Ye; Wang, Qiong; Li, Jin-Yan; Liao, Ce-Heng; Zhou, Zhi-Jian; Ge, Xing-Yi
title: Receptor utilization of angiotensin converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV
date: 2020-06-13
journal: bioRxiv
DOI: 10.1101/2020.06.13.149930
sha: 4a06dc6d674b3f0cd7b791ba181925d961dada79
doc_id: 1053142
cord_uid: kx0n2oy5

Coronavirus pandemics have become a huge threat to the public health worldwide in the recent decades. Typically, SARS-CoV caused SARS pandemic in 2003 and SARS-CoV-2 caused the COVID-19 pandemic recently. Both viruses have been reported to originate from bats. Thus, direct or indirect interspecies transmission from bats to humans is required for the viruses to cause pandemics. Receptor utilization is a key factor determining the host range of viruses which is critical to the interspecies transmission. Angiotensin converting enzyme 2 (ACE2) is the receptor of both SARS-CoV and SARS-CoV-2, but only ACE2s of certain animals can be utilized by the viruses. Here, we employed pseudovirus cell-entry assay to evaluate the receptor-utilizing capability of ACE2s of 20 animals by the two viruses and found that SARS-CoV-2 utilized less ACE2s than SARS-CoV, indicating a narrower host range of SARS-CoV-2. Meanwhile, pangolin CoV, another SARS-related coronavirus highly homologous to SARS-CoV-2 in its genome, yet showed similar ACE2 utilization profile with SARS-CoV rather than SARS-CoV-2. To clarify the mechanism underlying the receptor utilization, we compared the amino acid sequences of the 20 ACE2s and found 5 amino acid residues potentially critical for ACE2 utilization, including the N-terminal 20th and 42nd amino acids that may determine the different receptor utilization of SARS-CoV, SARS-CoV-2 and pangolin CoV. Our studies promote the understanding of receptor utilization of pandemic coronaviruses, potentially contributing to the virus tracing, intermediate host screening and epidemic prevention for pathogenic coronaviruses.

Coronaviruses are enveloped non-segmented positive sense RNA viruses. In the recent 51 two decades, human coronaviruses (HCoVs) have caused to at least three major 52 pandemics and pose a huge threat to the public health worldwide (1). Until now, seven 53 different HCoVs have been identified and all of them belong to the family 54

Coronaviridae of the order Nidovirales. Especially, the species Severe acute respiratory 55 syndrome-related coronavirus (SARSr-CoV) of the genus Betacoronavirus contains the 56 most pathogenic HCoVs, including severe acute respiratory syndrome coronavirus 57 (SARS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (2). 58 SARS-CoV caused the SARS pandemic in years of 2002 -2003, resulting in more than 59 8,000 clinical cases with a mortality of 10% (3, 4) . After the SARS pandemic, plenty of 60 research and measurements have been done to prevent the emergence and re-emergence 61 of coronavirus epidemics, including transmission tracing, pathogenesis studies and 62 therapy development (5). Nevertheless, 17 years later, a novel human coronavirus, 63 SARS-CoV-2, brought a much more severe and widespread pandemic of Coronavirus 64

Disease 2019 to the world and this pandemic is lasting until now (6, 7). Up 65 to May 25, 2025, about 5 month after the first reported case of COVID-19, SARS-CoV-66 2 has caused 5,432,302 confirmed infections and 342,318 deaths worldwide, far 67 surpassing the SARS pandemic. So far, most countries around the world are suffering 68 from the public health crisis, medical system overload and economic loss due to the 69 pandemic. Among common pathogenic viruses, SARS-CoV-2 emerges a high 70 transmissibility whose R0 value is currently estimated as 2.3 but could be as high as 5.7 71 when more infection cases are identified (8). The high transmissibility of SARS-CoV-2 72 is probably a major reason for the rapid development of COVID-19 epidemic. In order 73 to relieve the current pandemic and prevent HCoV epidemics in the future, more studies 74 on the transmission of pathogenic HCoV is urgently required. 75

Interspecies transmission from wide animals to humans is a major cause leading to 76 the epidemics of highly pathogenic coronaviruses, such as SARS-CoV and SARS-CoV-77 2. Previous virus tracing studies have shown that Chinese horseshoe bats are natural 78 reservoirs of SARS-CoV (9, 10), and a recent phylogenetic analysis has revealed that 79 SARS-CoV-2 might also be originated from bat-SARSr-CoV (11) as an exopeptidase expressed in vascular endothelial cells in the heart and the kidney 95 that catalyses the conversion of angiotensins (16, 17) . ACE2 is highly conserved and 96 ubiquitously expressed in most vertebrates, but not all ACE2s can serve as the receptor 97 for SARS-CoV and SARS-CoV-2, which is a key determinant of the host range of these 98 two viruses. For instance, SARS-CoV can use mouse ACE2 as its receptor but SARS-99

CoV-2 cannot, indicating that mouse is a potential host for SARS-CoV but not for 100 SARS-CoV-2 (1). Our previous study predicted the ACE2 utilization of SARS-CoV-2 101 and showed that SARS-CoV-2 could potentially utilize most mammalian ACE2s except 102 murine ACE2s and even some avian ACE2s. Meanwhile, we also predicted 9 amino 103 acid (aa) residues in ACE2 critical for SARS-CoV-2 utilization (18). However, this 104 study was mainly based on the aa analysis and lacked experimental evidence, which 105 could be hardly referred to clarify the host range of SARS-CoV-2. 106

In this study, we ectopically expressed ACE2 of 20 different animals in HeLa cells, a 107 cell line lacking of ACE2 expression naturally, and then infected the cells with HIV-108 based pseudoviral particles carrying coronavirus spike proteins to test their utilization of 109 these ACE2s. The result showed that both SARS-CoV and SARS-CoV-2 could use 110 most mammalian ACE2s as their receptors but not fish or reptilian ACE2s. Interestingly, 111 similar to mouse ACE2, SARS-CoV but not SARS-CoV-2 was capable of using 112 chicken ACE2, indicating a narrower host range of SARS-CoV-2, especially in murine 113

and birds. We also tested pangolin CoV pseudovirus with spike highly similar to SARS-114

CoV-2. To our surprise, pangolin CoV showed an ACE2 utilization profile similar to 115 SARS-CoV rather than SARS-CoV-2. By alignment of the aa sequence of the 20 ACE2 116 orthologs, we further confirmed several aa residues (among the 9 residues predicted 117 previously) critical for SARS-CoV-2 utilization, including T20, K31, Q42 and Y83, and 118 excluded some critical aa residues, such as Y41 and K68. Especially, T20 of ACE2 119 probably played critical roles in spike-ACE2 binding by interacting with S477 and T478 120 within the receptor-binding motif (RBM) of SARS-CoV-2 spike protein, but it was not 121 necessary for the binding of ACE2s with SARS-CoV and pangolin CoV spikes. These 122 aa residues might partially determine the unique receptor utilization and host range of 123 SARS-CoV-2. In summary, our study provides a more clear view of ACE2 utilization 124 by SARS-CoV-2, which may contribute to a better understanding about the virus-125 receptor interaction and the host range of SARS-CoV-2. 126 127 Results 128

In this study, we investigated the ACE2 utilization of three SARSr-CoVs, including 130 SARS-CoV-BJ01, SARS-CoV-2 and Pangolin CoV. Pangolin CoV was tested since 131 pangolins were suspected to be a potential intermediate host of . 132

Notably, the RBM of Pangolin CoV spike is almost identical with SARS-CoV-2 spike 133 except for the 498 th aa residue, but they are different from SARS-CoV spike on multiple 134 aa sites ( Figure 1A) . 135

In order to validate the successful preparation of the three pseudovirus, the HEK293T 136 cells for virus package were lysed after virus harvest the cells were lysed and subjected 137

to Western blot detection of HA-tagged spike proteins. As shown in Figure 1B To evaluate the phylogenetic relationship of the 20 ACE2s assessed above, we built a 172 phylogenetic tree based on the aa sequences of all the ACE2s (Figure 3A) . In the tree, 173 we observed the obvious branches of mammalian, bird, reptilia and fish ACE2s. 174 However, with the mammalian ACE2s, there were no significant branches 175 corresponding to the ACE2 utilization by SARS-CoV-BJ01 or SARS-CoV-2 176 pseudoviruses, indicating that the whole sequence analysis could hardly reveal the key 177 factors underlying the receptor utilization by the viruses. 178

In our previous study, we predicted 9 key aa sites on human ACE2 potentially 179 critical for the receptor utilization, including T20, K31, Y41, K68, Y83, K353, D355, 180 R357 and M383, based on the SARS-CoV-2 utilization of human, bat, civet, swine and 181 mouse ACE2s (18). Here we tested 15 more species, and then we checked the 9 sites of 182 the 20 ACE2 orthologs to validate the role of the nine sites in SARS-CoV-2 utilization. 183

As shown in Figure 3A , Y/H41, D355, R357 and R383 were conserved in all ACE2s, 184

indicating that these sites were not determining the receptor utilization by SARS-CoV-2. 185

Similarly, K68 was conserved in both mouse and chicken ACE2s that could not be used 186 by SARS-CoV-2 and was probably not important for SARS-CoV-2 utilization either. 187 Q42 was conserved in mouse ACE2 but was substituted by E42 in chicken ACE2 188 whose role in SARS-CoV-2 might be complicated. On the contrary, T20, K31 and Y83 189 in usable ACE2s were distinct from the corresponding aa in unusable ACE2s, indicating 190 their cirtical role in determining SARS- In history, most pandemic viruses originated from wild reservoir animals and 194 transmitted directly or indirectly to humans, such as Ebola virus from bats (19) The COVID-19 pandemic caused by SARS-CoV-2 is the most severe worldwide 202 pandemic in the recent years surpassing the SARS pandemic in 2003, so it is likely to 203 speculate that SARS-CoV-2 has a broad host range. Surprisingly, our cell-entry result 204

showed that SARS-CoV-2 had a smaller range of ACE2 utilization than SARS-CoV. 205 SARS-CoV-2 could not utilize mouse or chicken ACE2 which could be used by CoV, indicating a narrower host range of SARS-CoV-2, especially in murine and birds. 207

The reason is probably that the host range of SARS-CoV-2 is broad enough to support 208 its transmission from bats to humans, and lack of infection to some kinds of animals 209

does not affect such transmission due to redundant routes. Thus, it is not suggested to 210 over-interpret the determination of the host range on the possibility of a virus to cause 211 pandemics, especially for the viruses with broad host ranges. 212

Notably, SARS-CoV-2 has a better utilization of bat ACE2 than SARS-CoV. Though 213 SARS-CoV originate from bat-SARSr-CoV, the utilization of bat ACE2 by SARS-CoV 214 is quite limited which is supported by the previous reports (10, 21). According our 215 current results, SARS-CoV-2 utilizes Chinese horseshoe bat ACE2 much better than 216 SARS-CoV, indicating a higher homology between SARS-CoV-2 and its ancestor. This 217 speculation is supported by the phylogenetic analysis of viral genomes in the previous 218 study (1). 219

Our cell-entry result showed that SARS-CoV and SARS-CoV-2 could use a wide 220 variety of mammalian ACE2s, which is further supported by the reports about the 221 susceptibility of various mammals to SARS-CoV-2 infection (22). However, the 222 utilization of fish and reptilian ACE2s was quite poor for both SARS-CoV and SARS-223

CoV-2. This can be explained by the remote phylogenetic relationship between 224 fish/reptilian ACE2s and mammalian ACE2s. By comparison, bird ACE2s have closer 225 phylogenetic relationship with mammalian ACE2s, and thus, bird ACE2s could be used 226 by some but not all SARSr-CoVs, such as SARS-CoV. This indicates that SARSr-CoVs 227 are more likely to be transmitted by mammals and birds but not fish and reptiles, and 228 more attention should be paid to domestic mammals and birds to prevent CoV pandemic. 229

Our previous study predicted 9 critical aa residues on ACE2 orthologs based on the 230 aa sequence comparison of Chinese horseshoe bat, civet, swine and mouse ACE2s, 231 since these were the only ACE2s tested by SARS-CoV-2 utilization at that time (18). In 232

this study, we have tested 16 more ACE2s which could help to confirm or exclude 233 critical aa residues found previously. K31 and Y83 in human ACE2 were confirmed by 234 this study as critical aa residues for SARS-CoV-2 utilization. Substitutions of K31D and 235 Y83F were reported to abolish or strongly inhibit SARS-CoV binding (23, 24). Here we 236 have found more K31 substitutions abolishing SARS-CoV-2 utilization that chicken 237 ACE2 with K31E, crocodile and viper snake ACE2s with K31Q and mouse ACE2 with 238 K31N could not be utilized by SARS-CoV-2, matching our previous prediction. 239

Considering both chicken and mouse ACE2s could be utilized by SARS-CoV, K31 may 240 be a key aa residue leading to the different receptor utilization of SARS-CoV and 241 SARS-CoV-2. Also, chicken, mouse and viper snake ACE2s with Y83F could not be 242 utilized by SARS-CoV-2, consistent with our previous prediction and other former 243 reports. On the contrary, though Y41A was reported to abolish SARS-CoV binding (23), 244 horse ACE2 with Y41H could be used by SARS-CoV-2 well, indicating that Y41H 245 barely affect SARS-CoV-2 utilization. However, Chinese horseshoe bat ACE2 with 246 Y41H showed a relatively lower utilization by SARS-CoV-2 and even lower utilization 247 by SARS-CoV, indicating Y41H might decrease receptor utilization synergistically with 248 only with other unknown substitutions, especially for SARS-CoV. Substitution of K68 249 was reported to slightly inhibit SARS-CoV binding (23). Nevertheless, horse ACE2 250 with K68R could be used by SARS-CoV-2 well, indicating that K68R might not affect 251 SARS-CoV-2 utilization either. Crucian and viper snake ACE2 with K68I could not be 252 used by SARS-CoV-2, but these ACE2s contains so many other substitutions that we 253 may not attribute the abolishment of SARS-CoV-2 utilization to K68I. 254 Remarkably, our study revealed T20 of ACE2 as a potential key aa residue for 255 SARS-CoV-2 utilization. T20 has not been reported to affect SARS-CoV utilization but 256 mouse ACE2 with T20L and chicken ACE2 with T20V could not be used by SARS-257

CoV-2. T20 is located at the N terminus of most mature mammalian ACE2s (excluding 258 the signal peptide). According to the structure of SARS-CoV-2 receptor-binding domain 259 complexed with human ACE2, the N-terminal T20 of ACE2 is close to S477 and T478 260 of SARS-CoV-2 RBM ( Figure 3B ) (25). Both threonine and serine contain hydroxyl 261 radicals that allow them to form hydrogen bonds with each other. Thus, T20 of human 262 ACE2 is likely to bridge with S477 and T478 of SARS-CoV-2 spike via hydrogen 263 bonds, which stabilizes the ACE2-spike binding. However, L20 on mouse ACE2 and 264 V20 on chicken ACE2 are both aliphatic aa that cannot form hydrogen bonds to support 265 the ACE2-spike binding, which may impair the utilization of these two ACE2s by 266 SARS-CoV-2. In SARS-CoV spike, the two aa residues are substituted by G463 and 267 K464. K464 can form hydrogen bonds with threonine and G463 is a non-polar aa that 268 can interact with valine or leucine via hydrophobic bond together with the adjacent 269 A461. Therefore, SARS-CoV spike can interact with various N-terminal aa of ACE2s, 270 and this may be the reason why SARS-CoV can utilize mouse and chicken ACE2s 271 while SARS-CoV-2 cannot. Pangolin CoV spike shares high similarity with SARS-272

CoV-2 which keeps S477 and T478. However, Pangolin CoV spike harbors alkaline 273 H498 that can interact with acidic Q42 and E42 of mouse and chicken ACE2, 274 respectively, via ionic affinity, which may complementally support the ACE2-spike 275 binding and allow the utilization of mouse and chicken ACE2 by Pangolin CoV. On the 276 contrary, SARS-CoV-2 spike substitutes H498 with acidic Q498, leading to ionic 277 repulsion with Q42 and E42, blocking its binding with mouse and chicken ACE2s. 278 These proposed interactions provide a possible explanation for the different utilization 279 of ACE2s by SARS-CoV-2 and pangolin CoV. Nevertheless, all the speculation about 280 the aa residues on ACE2 key for spike-ACE2 binding is based on the sequence analysis, 281 and mutation validation is necessary to further verify the roles of those sites. 282

In summary, our current study has validated the ACE2 utilization by SARS-CoV-2 283 predicted in our previous analysis by pseudovirus cell-entry assay. The results showed 284 less ACE2 utilization by SARS-CoV-2 compared to SARS-CoV and pangolin CoV, 285 especially for murine and bird ACE2s, indicating narrower host range of SARS-CoV-2. 286

Meanwhile, with these data, we screend 5 key aa residues of ACE2 for SARS-CoV-2 287 utilization. Especially, the N-terminal T20 and Q42 might be critical in determining the 288 (Bioworld, USA, 1:5000) was used as the first antibody, followed by incubation with 318 HRP-conjugated goat anti-mouse IgG at the same dilution. 319

The pseudovirus cell-entry assay was performed as described previously (26) 

Writing -346 Original Draft, Y.Q.; Writing -Review & Editing

A pneumonia 353 outbreak associated with a new coronavirus of probable bat origin

Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics 356 comparison with SARS-CoV and MERS-CoV

360 4. Parry J. WHO warns that death rate from SARS could reach 10%

SARS and MERS: recent 363 insights into emerging coronaviruses

A Novel Coronavirus 365 from Patients with Pneumonia in China

A new coronavirus 367 associated with human respiratory disease in China

Epidemiology of COVID-19

Evidence of 371 the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like 372 coronavirus and its implications on the direct ancestor of SARS coronavirus

Isolation and 375 characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

Genomic characterisation and 378 epidemiology of 2019 novel coronavirus: implications for virus origins and receptor 379 binding

Isolation 381 and characterization of viruses related to the SARS coronavirus from animals in 382 southern China

Identifying 384 SARS-CoV-2 related coronaviruses in Malayan pangolins

Probable Pangolin Origin of SARS-CoV-2

Associated with the COVID-19 Outbreak

CoV S glycoprotein: expression and functional characterization

Advances in biochemical and functional 391 roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of 392 cardiovascular function

A 394 novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts 395 angiotensin I to angiotensin 1-9

Predicting the 397 angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-398 CoV-2. Microbes Infect. 2020. 399 19

Difference in receptor usage 405 between severe acute respiratory syndrome (SARS) coronavirus and SARS-like 406 coronavirus of bat origin

Susceptibility of 408 ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2

Receptor and viral 411 determinants of SARS-coronavirus adaptation to human ACE2

Receptor recognition by novel 414 coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. 415 J Virol

Structural basis of 417 receptor recognition by SARS-CoV-2

Receptor usage and cell 419 entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of 420 MERS coronavirus